Gilead Sciences launches Asia Pacific All4LIVER Grant 2021
The grant aims to empower organisations that can help bring liver health, in particular, viral hepatitis, to the forefront of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
viral hepatitis
Gilead Sciences to acquire MYR GmbH
Gilead to acquire Hepcludex, a first-in-class entry inhibitor, for treatment of chronic hepatitis delta virus (HDV), after closing…